Letters to the Editor

Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes

Amyloidosis Center and Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, MA
Amyloidosis Center and Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, MA
Amyloidosis Center and Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, MA
Amyloidosis Center and Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, MA
Amyloidosis Center and Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, MA
Amyloidosis Center and Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, MA
Amyloidosis Center and Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, MA
Haematologica Early view Dec 22, 2022 https://doi.org/10.3324/haematol.2022.282264